Craving Clinical Trial
— OdorCraveOfficial title:
Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving: A Neurobehavioral Investigation
The proposed study uses fMRI and behavioral measures in and outside the laboratory to investigate the neurobehavioral mechanisms underlying the impact of pleasant olfactory cues (OCs) on cigarette craving. The investigators plan to randomize 278 participants to a pleasant OC condition or an odor blank (neutral) condition and due to anticipated drop out expect to run 250 adult (half female) smokers, including both daily and nondaily smokers through the protocol. This study involves three visits. In the first visit, participants will complete a baseline breath carbon monoxide reading, a brief odor threshold test, and complete a series of self-report measures. In the next session, participants who are 8-hrs deprived of nicotine will undergo a 60-minute fMRI scan that will include structural, resting state, and task-based data collection. The fMRI task involves completing a series of tasks designed to index responses linked to key neural networks found to relate to addiction (e.g., reward processing, working memory). Participants will also be exposed to smoking cues to heighten craving and then depending on their condition (randomly assigned) will either receive a pleasant or neutral (odor blank) OC. In the third session, behavioral data will be collected to test the impact of either a pleasant or neutral OC on cigarette craving using self-reported urge and behavioral measures linked to craving. Finally, for pilot purposes designed to offer data for a subsequent clinical study (beyond this study), participants will additionally complete a 7-day ecological momentary assessment (EMA) protocol in which they will monitor cigarette craving and initial data will be collected outside the laboratory to evaluate the impact of OCs on naturally occurring craving. It is hypothesized that pleasant OCs will disrupt craving brain states and attenuate craving (as compared to neutral olfactory cues). Further, it is hypothesized that individual variation in neural responses to cognitive and affective tasks will reveal variation in mechanisms underlying pleasant OC craving reduction and that individual differences will moderate pleasant OC-induced craving relief. Finally, it is also expected that emotional responses to pleasant OCs will mediate the impact of OCs on craving and smoking-related processes.
Status | Recruiting |
Enrollment | 250 |
Est. completion date | June 2025 |
Est. primary completion date | June 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 49 Years |
Eligibility | Inclusion Criteria: - Aged 18-49 - Right-handed - Fluent in English - Intact sense of smell - Pass an MRI safety screening and along these lines will need to be 250lbs or less to safely enter the MRI - No drug dependence outside of nicotine or caffeine - Must fit into one of two categories of smokers, daily or nondaily, as confirmed by verbal self-report and a baseline CO reading; Daily smokers: must smoke 10-30 cigarettes per day for at least 12 months, Nondaily smokers: must smoke for 1-14 days of the last 30 days with no more than 20 cigarettes a day - Need to have access to a working smartphone to complete the ecological momentary assessment portion of the study Exclusion Criteria: - Medical conditions that contraindicate nicotine use - Not fluent in English - Illiterate - Current neurological or psychotic disorders - Current psychoactive drug use - MRI contraindications such as stroke history, pregnancy, metal in the body, history of aneurysms, or serious head injury - Individuals will also be excluded if they report any allergies to the odors used in our study. - Baseline CO readings will need to be consistent with our criteria for daily and nondaily smokers for participants to be considered eligible. Specifically, we plan to rule out extremely heavy smokers (nondeprived CO > 55, for whom the smoking abstinence requirement may be too extreme to allow a sensitive test of our OC manipulation) and daily smokers with a nondeprived CO reading <10 PPM as this would raise concerns that they do smoke enough to be classified as a daily smoker. |
Country | Name | City | State |
---|---|---|---|
United States | The University of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | National Center for Complementary and Integrative Health (NCCIH) |
United States,
Sayette MA, Marchetti MA, Herz RS, Martin LM, Bowdring MA. Pleasant olfactory cues can reduce cigarette craving. J Abnorm Psychol. 2019 May;128(4):327-340. doi: 10.1037/abn0000431. Epub 2019 Apr 15. — View Citation
Sayette MA, Parrott DJ. Effects of olfactory stimuli on urge reduction in smokers. Exp Clin Psychopharmacol. 1999 May;7(2):151-9. doi: 10.1037//1064-1297.7.2.151. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Disruption of the Craving Brain State by the Pleasant, Compared to the Neutral, Olfactory Cue | Condition difference in the Fisher Z-transformed correlation coefficient between the craving brain state and olfactory cue-induced brain state, where brain states are indexed as the fMRI contrast between cigarette cue (with, and without, odor) and control cue | within 1 month of enrollment; immediately before and after administration of the olfactory cue | |
Primary | Craving Observed During Pleasant Compared to Neutral OC Exposure Assessments, Controlling for Pre-OC Craving Ratings | Condition difference in self-reported urge on a 0 to 100 scale, with 0 equal to no urge to smoke at all, and 100 as the "strongest urge to smoke that I have ever felt" | between 1 and 10 days subsequent to the fMRI study visit; before and immediately after administration of the olfactory cue | |
Secondary | Strength of the Cognitive-Associated Neural Fingerprint Induced During the Pleasant Compared to Neutral Olfactory Cue | The condition difference in Fisher Z-transformed correlation coefficients between each cognitive domain neural fingerprint and olfactory cue-induced brain state | within 1 month of enrollment; during the fMRI scan | |
Secondary | Change in Craving from Peak Craving to the Craving Observed During Pleasant, Compared to Neutral, Olfactory Cues as Measured by a Pressure-Sensitive Squeeze Device | Condition difference in behavioral response on a dynamometer pressure-squeeze device, measured as pressure force (intensity x duration) | between 1 and 10 days subsequent to the fMRI study visit; immediately before and after administration of the olfactory cue | |
Secondary | Mediating Role of the Emotional Response to the Pleasant Olfactory Cue, as Indexed by the Facial Action Coding System, on the Impact of Pleasant Olfactory Cues on Self-Reported Craving | Mediating effect of emotional response, as measured by the Duchenne smile in the Facial Action Coding System, on the effect of olfactory cues on self-reported urge, indexed using the 0-100 urge rating scale | between 1 and 10 days subsequent to the fMRI study visit; immediately before and after administration of the olfactory cue |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03576768 -
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
|
N/A | |
Not yet recruiting |
NCT06026982 -
Gut Health and the Effect on Substance and Alcohol Cravings
|
Early Phase 1 | |
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Completed |
NCT05074524 -
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
|
N/A | |
Completed |
NCT03112824 -
Functional Assessment of Ashwagandaha Root Extract During Weight Loss
|
N/A | |
Completed |
NCT03758027 -
CARESS: An Investigation of Effects of CARESS
|
N/A | |
Not yet recruiting |
NCT03217929 -
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Craving in Obese Individuals.
|
N/A | |
Completed |
NCT01030289 -
The Effectiveness of Transcranial Direct Current Stimulation (tDCS) in Decreasing Food Cravings
|
N/A | |
Withdrawn |
NCT04077385 -
Memory-Updating Technique to Reduce Food Craving and High Calorie Food Intake Among Individuals With Overweight/Obesity
|
N/A | |
Completed |
NCT04310423 -
An Inflammatory Challenge Using Endotoxin
|
Phase 2 | |
Recruiting |
NCT05076201 -
Process of Regulation in Addictions: Vulnerability Emotional Factors to Craving
|
N/A | |
Not yet recruiting |
NCT06129461 -
A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy
|
N/A | |
Recruiting |
NCT04338178 -
Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients.
|
N/A | |
Terminated |
NCT04162145 -
BRIDGE Device for Treatment of Opioid Withdrawal
|
N/A | |
Completed |
NCT05430685 -
The Impact of Ashwagandha on Perceived Stress, Sleep and Food Cravings in College Students
|
Phase 2 | |
Recruiting |
NCT04154111 -
Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users
|
N/A | |
Recruiting |
NCT05277714 -
Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
|
N/A | |
Completed |
NCT04936594 -
TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)
|
N/A | |
Enrolling by invitation |
NCT05336188 -
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
|
Phase 2 | |
Recruiting |
NCT04850664 -
Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder
|
Phase 2 |